{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:44:20Z","timestamp":1759229060907},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ijpharm.2005.02.035","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T01:27:36Z","timestamp":1116120456000},"page":"50-61","source":"Crossref","is-referenced-by-count":28,"title":["Impurity formation studies with peptide-loaded polymeric microspheres"],"prefix":"10.1016","volume":"297","author":[{"given":"Santos B.","family":"Murty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.C.","family":"Thanoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P.","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2005.02.035_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1023\/A:1007582911958","article-title":"Visual evidence of acidic microenvironment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres","volume":"17","author":"Fu","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0939-6411(97)00125-2","article-title":"Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods","volume":"45","author":"Hermmann","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0168-3659(95)00125-5","article-title":"Effect of solvent removal technique on the matrix characteristics of polylactide\/glycolide microspheres for peptide delivery","volume":"38","author":"Jeyanthi","year":"1996","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2005.02.035_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/02652049709015330","article-title":"Effect of processing parameters on the properties of peptide-containing PLGA microspheres","volume":"14","author":"Jeyanthi","year":"1997","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1081\/PDT-100102043","article-title":"Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres","volume":"5","author":"Kostanski","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1208\/pt010104","article-title":"A novel in vitro release technique for peptide-containing biodegradable microspheres","volume":"1","author":"Kostanski","year":"2000","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1014272816454","article-title":"Peptide acylation by poly(alpha hydroxy esters)","volume":"19","author":"Lucke","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(02)00020-2","article-title":"The effect of poly(ethylene glycol)-poly(d,l-lactic acid) diblock copolymers on peptide acylation","volume":"80","author":"Lucke","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2005.02.035_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0939-6411(02)00138-8","article-title":"Acylation of peptides by lactic acid solutions","volume":"55","author":"Lucke","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib10","first-page":"3","article-title":"Analysis of accelerated in vitro release profiles for PLA microspheres loaded with an LHRH antagonist decapeptide","volume":"3","author":"Murty","year":"2001","journal-title":"AAPS Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib11","unstructured":"Murty, S.B., 2003a. Drug stability and release kinetics of a somatostatin analogue formulated in polymeric biodegradable microspheres. Ph.D. Thesis, University of Kentucky, USA."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1208\/pt040450","article-title":"Identification of chemically modified peptide from poly (d,l-lactide-co-glycolide) microspheres under in vitro release conditions","volume":"4","author":"Murty","year":"2003","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/pt050349","article-title":"In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil\/water and oil\/oil processes","volume":"5","author":"Murty","year":"2004","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0939-6411(00)00066-7","article-title":"Formation of peptide impurities in polyester matrices during implant manufacturing","volume":"49","author":"Rothen-Weinhold","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib15","unstructured":"Thanoo, B.C., Murtagh, J., 1998. Continuous microsphere process. US Patent 5,945,126 (31 August)."},{"key":"10.1016\/j.ijpharm.2005.02.035_bib16","unstructured":"Thanoo, B.C., Murtagh, J., 2001. Method and apparatus for formulating microspheres and microcapsules. US Patent 6,270,802 (7 August)."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517305001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T08:27:26Z","timestamp":1548491246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517305001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0378517305001791"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2005.02.035","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}